Can a DNA vaccine boost immunotherapy against HPV-Linked head and neck cancer?
Disease control
Recruiting now
This trial is testing whether an experimental DNA vaccine called VB10.16, when combined with the standard immunotherapy drug pembrolizumab, can help people with a type of head and neck cancer linked to HPV16. The study includes adults with recurrent or metastatic cancer in the or…
Phase 1/2 • Sponsor: Nykode Therapeutics ASA • Aim: Disease control
Last updated Aug 28, 2026 00:00 UTC